Werewolf Therapeutics (HOWL) has made great progress thus far in advancing its IL-2 drug known as WTX-124 for the treatment of patients with advanced or metastatic solid tumors. It has an ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results